Home  »  Companies   »  What should you know before buying stock in China ...

What should you know before buying stock in China Pharma Holdings Inc. (CPHI)

China Pharma Holdings Inc. (AMEX: CPHI) is 20.96% higher on its value in year-to-date trading and has touched a low of $0.08 and a high of $0.53 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CPHI stock was last observed hovering at around $0.11 in the last trading session, with the day’s gains setting it 0.01% off its average median price target of $4.50 for the next 12 months. It is also 97.33% off the consensus price target high of $4.50 offered by 1 analysts, but current levels are 97.33% higher than the price target low of $4.50 for the same period.

Currently trading at $0.12, the stock is 9.42% and 3.77% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.38 million and changing 8.31% at the moment leaves the stock -37.65% off its SMA200. CPHI registered -68.22% loss for a year compared to 6-month loss of -44.79%.

5 Undervalued Stocks For 2023

Approximately 544 miles north of Las Vegas lies what's been dubbed "the biggest lithium deposit in the US." One tiny company stands to be the biggest beneficiary because lithium "faces a long-term supply shortage," according to Barron's. This company, however, is sitting on a goldmine opportunity as it plans to produce 30,000 tonnes per annum over the next 3.5 years from this single deposit. Supplying the electric vehicle boom and potentially driving its stock price off the charts. But this is just one of the opportunities we have researched in our free report. The other four companies have just as much potential.

Click here to download your Free Copy…

Sponsored

The stock witnessed a -1.61% gain in the last 1 month and extending the period to 3 months gives it a -16.55%, and is 7.01% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.47% over the week and 12.20% over the month.

China Pharma Holdings Inc. (CPHI) has around 236 employees, a market worth around $5.64M and $8.10M in sales. Profit margin for the company is -45.70%. Distance from 52-week low is 45.00% and -77.95% from its 52-week high. The company has generated returns on investments over the last 12 months (-18.30%).

China Pharma Holdings Inc. (CPHI) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for China Pharma Holdings Inc. (CPHI) is a “Buy”. 1 analysts offering their recommendations for the stock, where 0 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

China Pharma Holdings Inc. is expected to release its quarterly report on 05/18/2023.The EPS is expected to shrink by -12.10% this year.

China Pharma Holdings Inc. (CPHI) Top Institutional Holders

The shares outstanding are 50.02M, and float is at 23.36M with Short Float at 1.05%.

China Pharma Holdings Inc. (CPHI) Insider Activity

A total of 0 insider transactions have happened at China Pharma Holdings Inc. (CPHI) in the last six months, with sales accounting for 0 and purchases happening 0 times.

China Pharma Holdings Inc. (CPHI): Who are the competitors?

The company’s main competitors (and peers) include Johnson & Johnson (JNJ) that is trading 2.09% up over the past 12 months and Sanofi (SNY) that is -4.78% lower over the same period. Novartis AG (NVS) is 5.73% up on the 1-year trading charts.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts